• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    68.56 Up 1.23(1.83%) Feb 27, 4:00PM EST
    |After Hours : 68.56 0.00 (0.00%) Feb 27, 7:59PM EST
    Add to Portfolio
    Prev Close:67.33
    Open:67.81
    Bid:N/A
    Ask:80.00 x 200
    1y Target Est:65.00
    Beta:1.31
    Next Earnings Date:N/A
    Day's Range:67.02 - 69.98
    52wk Range:22.25 - 75.24
    Volume:7,527,856
    Avg Vol (3m):3,426,470
    Market Cap:8.10B
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ISISUp 1.83%8.10B
    ENZUp 0.33%136.94M
    GILDDown 0.63%154.20B
    SRPTUp 0.58%574.22M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):46.37
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.13
    Quarterly EPS Est (Mar-15) :-0.28
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-2.63

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback